Q3 2023 · 13F-HR
BML Capital Management, LLCholdings as filed
Filed 2023-10-23 · accession 0001754960-23-000287
$108.9M
Reported value
26
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46436E718 | SGOV | ISHARES TR | $27.2M | 25.0% | 270,000 | Common | NONE |
| 78468R663 | BIL | SPDR SER TR | $18.4M | 16.9% | 200,000 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $14.4M | 13.2% | 4,800,000 | Common | NONE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $9.2M | 8.48% | 3,250,008 | Common | NONE |
| 05455M100 | — | AVROBIO INC | $6.2M | 5.66% | 4,001,627 | Common | NONE |
| 00773U108 | ADVMCHF | ADVERUM BIOTECHNOLOGIES INC | $5.9M | 5.39% | 3,915,000 | Common | NONE |
| 87410C104 | — | TALARIS THERAPEUTICS INC | $5.6M | 5.16% | 2,000,000 | Common | NONE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $5.1M | 4.68% | 1,938,263 | Common | NONE |
| 04746L104 | — | ATHIRA PHARMA INC | $3.4M | 3.16% | 1,704,362 | Common | NONE |
| 046484309 | ASTC | ASTROTECH CORP | $2.2M | 2.04% | 220,410 | Common | NONE |
| 68403P203 | ORMP | ORAMED PHARMACEUTICALS INC | $2.0M | 1.87% | 781,292 | Common | NONE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $1.4M | 1.30% | 706,930 | Common | NONE |
| 702712100 | — | PASSAGE BIO INC | $1.4M | 1.24% | 2,058,767 | Common | NONE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $1.2M | 1.07% | 1,761,702 | Common | NONE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $844,750 | 0.78% | 272,500 | Common | NONE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $683,000 | 0.63% | 50,000 | Common | NONE |
| 76129W105 | RVP | RETRACTABLE TECHNOLOGIES INC | $594,951 | 0.55% | 499,959 | Common | NONE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $582,750 | 0.54% | 150,000 | Common | NONE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $524,000 | 0.48% | 100,000 | Common | NONE |
| 128058302 | LSTA | LISATA THERAPEUTICS INC | $521,815 | 0.48% | 243,839 | Common | NONE |
| 46090E103 | QQQ | INVESCO QQQ TR | $443,880 | 0.41% | 108 | PUT | NONE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $395,340 | 0.36% | 306,465 | Common | NONE |
| 64049K203 | — | NEOLEUKIN THERAPEUTICS INC | $389,723 | 0.36% | 98,664 | Common | NONE |
| 38942Q202 | CALC | CALCIMEDICA INC | $236,113 | 0.22% | 88,781 | Common | NONE |
| 75082Q105 | — | RAIN ONCOLOGY INC | $62,848 | 0.06% | 72,926 | Common | NONE |
| 86889P109 | — | SURROZEN INC | $43,743 | 0.04% | 89,271 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.